| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 83950 | A 050165L302 | 0.049093561024907 | 0.081657441 |
| NSC 622297 | Null | 0.0490935610249072 | 0.3327315 |
| NSC 625731 | Null | 0.0490935610249072 | 0.39119046 |
| NSC 626879 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride | 0.0490935610249072 | 0.37152323 |
| NSC 631136 | Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- | 0.0490935610249072 | 0.28734294 |
| NSC 639541 | Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- | 0.0490935610249072 | 0.43532014 |
| NSC 658143 | 2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin | 0.0490935610249072 | 0.44512013 |
| NSC 666123 | Null | 0.0490935610249072 | 0.72738073 |
| NSC 666787 | Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate | 0.0490935610249072 | 0.34954549 |
| NSC 685981 | 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- | 0.0490935610249072 | 0.51626101 |